115 articles - From Friday Oct 17 2025 to Friday Oct 24 2025
Guidelines and related publications, position statements, white papers, technical reviews, consensus statements, etc…
| Gastroenterology |
|---|
| AGA Clinical Practice Guideline on Surveillance of Barrett's Esophagus.
This document provides a comprehensive outline on the role of surveillance in patients with BE. Key implementation statements included in this document stress the importance of a high-quality endoscopy examination, sampling using a structured biopsy protocol, and confirming the diagnosis of BE-related neoplasia by an expert pathologist. This document also provides guidance on surveillance intervals and management of patients with BE-related low-grade dysplasia and indefinite for dysplasia. Providers should engage in shared decision making based on patient preferences. Limitations and gaps in the evidence are highlighted to guide future research opportunities. Guideline endorsement This guideline is endorsed by the Canadian Association of Gastroenterology. |
| AGA Clinical Practice Update on Endoscopic Resection for Early Colorectal Cancer: Commentary.
The target audience for this commentary includes primary care, gastroenterology, pathology, and surgical health care professionals. Methods This expert commentary was commissioned and approved by the AGA Institute Clinical Practice Updates Committee (CPUC) and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership and underwent internal peer review by the CPUC and external peer review through standard procedures of Gastroenterology. |
| AGA Clinical Practice Update on the Management of Ascites, Volume Overload, and Hyponatremia in Cirrhosis: Expert Review.
Cautious escalation can be done every 2-3 days with monitoring of volume status, kidney function, daily weights, and symptoms. BEST PRACTICE ADVICE 13: Advanced strategies in refractory anasarca should be coordinated with nephrology for consideration of diuretics in the setting of contraction alkalosis (eg, addition of acetazolamide), second agent with alternate mechanism of actions (eg, thiazide diuretics, such as metolazone), or need for ultrafiltration. |
| Gastrointest Endosc |
| Consensus and consequences: Does the Baveno consensus deliver improved outcomes and survival? |
meta-analyses and systematic reviews
| Aliment Pharmacol Ther |
|---|
| Meta-Analysis: Immune-Related Adverse Events Are Associated With Improved Effectiveness of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.
irAEs, particularly dermatologic, endocrine and low-grade events, were associated with improved ICIs' effectiveness in HCC. Early irAEs detection and corticosteroid management preserve survival benefits. However, more large-scale prospective studies are needed to verify our findings. |
| Am J Gastroenterol |
| Excessive Intrapancreatic Fat Deposition and Risk of Pancreatic Diseases: Longitudinal Cohort Evidence from a Systematic Review with Population-Attributable Fraction Analysis.
Longitudinal evidence generally supports the hypothesized role of excessive IPFD as a key contributor to the risk of major pancreatic diseases. The potential benefits of reducing IPFD appear to be greatest for acute pancreatitis and pancreatic cancer. |
| Reevaluating the Role of Proton Pump Inhibitors After Endoscopic Band Ligation of Esophageal Varices in Cirrhotic Patients: A Systematic Review and Meta-analysis.
Current evidence is insufficient to support routine PPI use after EBL. RCT data remains underpowered and inconclusive, emphasizing the need for adequately powered trials. |
| Gastrointest Endosc |
| 2025 best of systematic reviews and meta-analyses in gastrointestinal endoscopy. |
RCT, clinical trials, retrospective studies, etc…
| Aliment Pharmacol Ther |
|---|
| Clinical Trial: Simplified Bowel Preparation for Small Bowel Capsule Endoscopy in Crohn's Disease.
A simplified preparation consisting of a clear liquid diet and water is a viable alternative to a PEG-based preparation prior to SBCE in patients with CD, offering comparable SB cleanliness and diagnostic outcomes while improving acceptability. |
| Effects of Resmetirom on Metabolic-Dysfunction Associated Steatohepatitis in Patients With Weight Loss and/or Diabetes Taking Glucagon-Like Peptide-1 Receptor Agonists and Other Diabetes Therapies: A Secondary Analysis of the MAESTRO-NASH Trial.
The efficacy of resmetirom on multiple MASH endpoints was not impacted by background SGLT2i or GLP-1 RA treatment. Weight loss (≥ 5%) enhanced the efficacy of resmetirom. |
| High Risk of Colorectal Cancer After High-Grade Dysplasia in Inflammatory Bowel Disease Patients.
The risk of synchronous and metachronous CRC after a diagnosis of high-grade dysplasia underlines the high-risk profile of this subgroup of patients with inflammatory bowel disease. The possible advantages of colon-sparing treatment should be balanced with the higher risk of metachronous CRC and the subsequent need for stringent endoscopic surveillance. |
| Maternal and Perinatal Outcomes in Pregnant Women With Comorbid Inflammatory Bowel Disease and Chronic Liver Disease.
Coexisting IBD and CLD confer compounded maternal and perinatal risks beyond either condition alone. Multidisciplinary care and risk-based screening for underlying CLD in pregnant women are warranted. |
| Persistence of Symptoms of Anxiety and Depression in Inflammatory Bowel Disease: A Longitudinal Follow-Up Study.
Poor psychological health persists for a substantial number of patients with IBD. Further work is needed to establish the long-term effect of mood trajectories on disease outcomes. |
| Research Communication: Changing Aetiology of Chronic Liver Diseases in East Asia Pacific and HCC Surveillance in Non-Cirrhotic Patients.
HCC surveillance in non-cirrhotic patients was cost-effective only for chronic hepatitis B in selected older age groups, with substantial variability across countries. These findings support refining surveillance guidelines and adaptation of risk stratification tools. |
| Research Communication: Teriflunomide Does Not Affect Gluten-Specific T-Cell Activity in Coeliac Disease-A Randomised, Placebo-Controlled Trial.
The main aim was to observe attenuation of gluten-specific T-cell activation markers after gluten exposure. We found no significant differences in T-cell activity between groups, concluding that teriflunomide is ineffective as a non-dietary treatment for coeliac disease. |
| Treatment-Free Outcomes Following Surgery for IBD: A Nationwide Cohort Study.
Surgery obviated the need for future therapy in 22% of patients with CD and 42% with UC. Absence of extraintestinal manifestations, older age in UC, and longer disease duration and absence of chronic obstructive pulmonary disease in CD may highlight an opportunity for precision surgery to identify those most likely to achieve long-term benefit from surgical intervention. |
| Am J Gastroenterol |
| Comparative Safety of Advanced Therapies in Patients with Ulcerative Colitis: An Administrative Claims-based Study.
In a real-world cohort of patients with UC, anti-interleukins and JAK inhibitors were associated with lower risk of serious infections and may offer net benefit, especially in patients with prior TNF antagonist exposure. |
| Demodicosis Mimics Acneiform Eruptions in Patients with Inflammatory Bowel Disease Receiving Upadacitinib: A Case Series.
Demodicosis should be considered in patients with IBD having acneiform eruptions, particularly those receiving upadacitinib. |
| Effects of Screening Colonoscopy: Evidence From Observational and Interventional Studies.
We conclude that, despite apparent differences in reported results, both observational and interventional provide compelling evidence for strong preventive effects of screening colonoscopy. On the population level, similarly strong incidence and mortality reduction might be reached by well-organized screening programs achieving higher adherence rates with less invasive screening tests. |
| Impact of Artificial Intelligence Use on Endoscopist Optical Diagnosis of Sessile Serrated Lesions, Traditional Serrated Adenomas and Advanced Conventional Adenomas.
CADx use did neither significantly harm nor improve optical diagnostic performance for SSLs despite CADx inability to classify SSLs. |
| Per-oral endoscopic myotomy-induced reduction of crural diaphragm contractility might contribute to development of post-procedural reflux esophagitis.
POEM can impair CD contraction, and weak CD contraction was associated with post-POEM RE. |
| The Risk of Hypertensive Disorders of Pregnancy in Inflammatory Bowel Disease.
While the risk of hypertensive disorders of pregnancy overall was not increased in pregnancies affected by IBD, there was an increased risk of preeclampsia. This may reflect underlying immune-mediated placental dysfunction. |
| The impact of E-Cigarettes and Heat-Not-Burn Tobacco on Postoperative Recurrence of Crohn's Disease: A Multicenter International Study.
HNBT, and possibly e-cigarettes, are associated with increased endoscopic recurrence of CD compared to non-smoking. |
| Utility of quantitative fecal immunochemical test values for average risk colorectal cancer screening risk stratification among patients with a positive test.
Neoplastic findings occurred across the whole spectrum of qFIT values, emphasising the need for colonoscopy for al positive qFIT tests. However, increasing qFIT values correlated with the PPV for CRC and advanced adenoma and may help to stratify patients at highest risk for detecting serious neoplastic lesions in resource-constrained settings. |
| Clin Gastroenterol Hepatol |
| Recent Trends of Incidence, Mortality, Treatment, and Overall Survival of Hepatocellular Carcinoma in the United States.
HCC incidence rates have started to decline, and incidence-based mortality has plateaued. Given lower early-stage detection and curative treatments during the COVID-19 pandemic, longer-term follow-up is warranted to assess the impact on survival. The reduced survival disparities between non-Hispanic Black and White patients may reflect improved equitable medical access. |
| Seroprevalence of Helicobacter pylori infection among asymptomatic patients served by a safety-net healthcare system.
In this population-based study, almost two-thirds of asymptomatic patients were seropositive for H. pylori. Prevalence was over 40% among al sub-groups. Screening solely based on race and ethnicity may inadvertently exacerbate disparities by overlooking confounding factors for infection like low socioeconomic status and regional exposures. |
| Endoscopy |
| Individuals with polyps ≥10mm without other high-risk features have a similarly low post-colonoscopy colorectal cancer risk as those with no polyps.
PCCRC-risk 5 years after baseline colonoscopy within individuals with polyps ≥10mm without other high-risk features is not significantly different from individuals without polyps at baseline. Lengthening surveillance intervals would affect 79% of high-risk individuals with ≥10mm polyps as their sole high-risk feature, and 46% if limited to those with 10-20mm polyps. |
| Intraductal Cryobiopsy via Percutaneous Cholangioscopy for Biliary Strictures: a Multicenter Feasibility Study.
This feasibility study showed that intraductal cryobiopsy via percutaneous cholangioscopy yielded larger samples and may enable more detailed histologic assessment than forceps biopsies. Further studies will evaluate its accuracy, safety, and potential for use with peroral cholangioscopy during ERCP. |
| Gastroenterology |
| Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn's Disease: 2025 AGA Evidence Synthesis.
Using Grading of Recommendations, Assessment, Development and Evaluation to appraise quality of evidence, this updated network meta-analysis can inform positioning of advanced therapies for the treatment of biologic-naïve and biologic-exposed patients with moderate-to-severe CD. |
| Intestinal LKB1 Loss Drives a Premalignant Program Along the Serrated Cancer Pathway.
Heterozygous loss of LKB1 pushes intestinal cells into a chronic regenerative state, which is amplified on loss of heterozygosity. Lkb1 deficiency thereby generates fertile ground for serrated colorectal cancer formation in the intestine, potentially explaining the increased cancer risk observed in PJS. |
| Retraction Notice to: "CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure" Gastroenterology 2015;149:1896-1909.e14.
The authors requested that this paper be retracted in 2019, and the Editors of Gastroenterology agree that this manuscript should be retracted. Dr Daniel Antoine played no part in any other aspects of this manuscript, and the authors have confidence in al other data. |
| Gastrointest Endosc |
| Best practices for Endoscopic Ultrasound-guided Gastroenterostomy: technical recommendations from an International modified Delphi process.
Despite technical differences (such as the preference of a jejunal catheter or a double-balloon catheter) most EUS-GE experts agree on key technical principles, providing valuable guidance on the standardization of EUS-GE in clinical practice. Conversely, certain topics show limited agreement, identifying future research priorities in the field of EUS-GE. |
| Extended Surveillance After Piecemeal Endoscopic Mucosal Resection: A Safe Approach to Initial Surveillance in Low-Risk Patients.
A risk-stratified approach may safely extend surveillance to 12 months for lower-risk patients following piecemeal EMR, reducing unnecessary procedures without compromising care. |
| Peroral cholangioscopy-guided laser-stricturoplasty for intrahepatic benign biliary strictures (with video).
This pilot study suggests that POCS-LAS is a technically feasible and potentially effective treatment for intrahepatic BBS. |
| Gut |
| PDE5A<sup>+</sup> cancer-associated fibroblasts enhance immune suppression in gastric cancer.
Our study elucidates the intricate role of PDE5A + CAFs in shaping the immunosuppressive TME in GC, providing mechanistic insights and therapeutic potential for combating this aggressive malignancy. |
| SMYD2-mediated methylation of STAT1 protects against hepatic ischaemia/reperfusion injury by blocking JAK-STAT1 signalling pathways.
This study establishes SMYD2 as a novel negative regulator of STAT1 activity through K175 methylation, providing new insights into the epigenetic control of STAT1 during hepatic I/R injury. Our findings reveal a previously unrecognised mechanism for fine-tuning STAT1 signalling in hepatic I/R injury, and targeting the SMYD2-STAT1 axis may present a promising therapeutic strategy for mitigating I/R-associated liver damage. |
| iPSC-induced multilineage liver organoids, small intestinal organoids and brain organoids sustain pangenotype hepatitis E virus propagation.
This study established iPSC-induced multilineage organoid infection models, confirming HEV's capacity for pan-tissue infection and revealing potential pathogenic mechanisms in the liver, intestine and nervous system. This platform provides valuable tools for HEV virology research and antiviral drug development, underscoring the unique value of organoid technology in infectious disease research. |
| Hepatology |
| Glutamine synthetase loss in β-catenin-mutant hepatocellular carcinoma promotes tumor burden through macrophage metabolic reprogramming.
We demonstrate unique metabolic dependency of β-catenin-mutated HCCs on GS in tumor cells which is diverted to macrophages upon GS elimination in tumor cells. This adaptation alters macrophage metabolism and function leading to compromised immunosurveillance and greater tumor burden. Our study reveals a metabolic dynamic between HCC cells and macrophages with impact on tumor biology. |
| Hepatectomy alters adjuvant anti-PD-1 action in a mouse model of HCC but does not compromise neoadjuvant efficacy.
Partial hepatectomy disrupts antitumor immunity and limits adjuvant ICI efficacy. Neoadjuvant anti-PD-1 immunotherapy offers a superior strategy compared to adjuvant immunotherapy in enhancing immune responses and reducing HCC recurrence. |
| MSR1+ macrophages passivate antitumor immunity by inducing ITM2A+ CD4T exhaustion differentiation.
MSR1+macrophages promote tumor-infiltrating ITM2A+CD4T exhaustion differentiation by regulating the ITM2A-ZAP70 axis. ZEA-αCD4 specifically targeted MSR1-ITM2A interaction to activate antitumor immunity and improve the efficacy of αPDL1 immunotherapy. |
| Reclassifying pediatric NAFLD using the steatotic liver disease framework: a multicenter retrospective study from the NASH CRN.
Most children with NAFLD met MASLD criteria, but nearly 1 in 6 were reclassified based on alcohol use or medication exposure. These findings highlight the need for a systematic diagnostic approach accounting for metabolic risk factors, alcohol use, and medication-related liver injury. |
| Serum bile acid levels predict the development of portal hypertension and high-risk esophageal varices following successful Kasai in biliary atresia.
In biliary atresia patients with successful KP, sBA is an early biomarker predicting the development of PH and HRV within 5 years post-KP. |
| J Hepatol |
| HBx-induced HSPB1 is a potential therapeutic target owing to its modulation of HBV cccDNA and hepatic immune responses.
HSPB1 represents a novel therapeutic target by modulating HBV cccDNA and immune responses in the liver. D-TK is a promising clinical candidate for HBV treatment through cccDNA suppression and immune activation. Impact and implications Chronic infection with HBV remains a significant global health concern, and current therapeutic options are inadequate. In this study, we demonstrate that HBx-induced elevation of HSPB1 contributes to the regulation of HBV cccDNA and the hepatic immune responses. We engineered a peptide, D-TK, that targets HBx, effectively suppresses cccDNA, and activates immune responses through HSPB1. Our findings offer new insights into the mechanism by which HBx-induced HSPB1 modulates HBV cccDNA and immune regulation in the liver. |
| Microbial metabolism dysfunction induced by transarterial chemoembolization aggravates postprocedural liver injury in HCC.
This is the first study to identify gut microbiota disturbance, i.e., deficiency of L. reuteri metabolite ILA, as significant cause of TACE-LI. L. reuteri and ILA administration serves as promising therapeutic approach for TACE-LI, which is crucial for reducing TACE adverse effects to achieve better prognosis in HCC. Impact and implications The majority of patients with hepatocellular carcinoma (HCC) are diagnosed losing the chance of surgical resection. Transarterial chemoembolization (TACE) is widely used for treating unresectable HCC; however, its long-term outcome is significantly limited by its main complication, i.e., liver injury (LI). In addition to traditional cognition of the direct liver damage of the ischemic necrosis or regional chemotherapy induced by TACE, the deeper mechanisms underlying TACE-induced LI (TACE-LI) remain largely unclear. Gut microbiota can modulate various liver diseases but its exact role in TACE-LI has not been reported. We found that TACE could disturb the gut microbiota. This disturbance was characterized by reduced levels of Limosilactobacillus reuteri (L. reuteri) and its metabolite indole-3-lactic acid (ILA), which were correlated with aggravated TACE-LI and poor overall survival in HCC. Administration of L. reuteri or ILA significantly improved TACE-LI by inhibiting the inflammation of macrophages. Our study is the first report highlighting gut microbiota disturbances as an important cause of TACE-LI; administration of L. reuteri or ILA represents a viable and secure strategy for preventing TACE-LI, thereby reducing the adverse effects of TACE and yielding better prognoses in patients with HCC. |
Plenty of the editorials are available as full text through the publisher website using the provided link
| Clin Gastroenterol Hepatol |
|---|
| Metabolic comorbidities accelerate liver fibrosis in chronic hepatitis B - time to act. |
| Gastroenterology |
| Refining Risk Stratification in MASLD: Moving Beyond Histology with individualized Noninvasive Predictive Models for Clinical Events. |
| Gastrointest Endosc |
| A note from the Editor-in-Chief. |
| Closing the door after endoscopic ultrasound-directed transgastric intervention: Have we found the sweet spot? |
| Cost-effectiveness of lowering the age of colorectal cancer screening in average-risk individuals to 45 years in Asia. |
| Endoscopic submucosal dissection for esophageal squamous cell carcinoma: from first-line therapy to salvage strategy in complex recurrences. |
| Endosonographic-guided tissue acquisition for solid pancreatic lesions: Have we reached the ceiling? |
| Post-endoscopic retrograde cholangiopancreatography pancreatitis appears less common but more costly than once thought. |
| Post-endoscopic retrograde cholangiopancreatography pancreatitis risk with self-expandable metal biliary stents: what we know and what still needs to be done. |
misc publications eg case reports, tools of the trade, images of the month, etc…
| Am J Gastroenterol |
|---|
| Bump on the head: An unusual presentation of pancreas adenocarcinoma. |
| Colonic Coil Conundrum. |
| Extramedullary myeloma presenting as melena and severe anemia. |
| Finding Waldo: An elusive source of GI bleeding. |
| First reported case of human infection with Helicobacter cynogastricus. |
| Large bowel pharmacobezoar. |
| Mantle cell lymphoma manifests in multiple morphologies within the colorectum. |
| OPTICAL DIAGNOSIS OF APPENDICEAL MUCINOUS NEOPLASM THROUGH EXPRESSION OF MUCIN WITH UNROOFING TECHNIQUE. |
| Practical Considerations for the use of Semaglutide in MASH. |
| Strategies for Navigating the Transition from Pediatric to Adult Gastroenterology Care. |
| Clin Gastroenterol Hepatol |
| Root-Cause Analysis of Post-Endoscopy Esophageal Neoplasia in a Multicenter Prospective Barrett's Esophagus/Esophageal Adenocarcinoma Registry. |
| Endoscopy |
| A case in which all stones, including gallbladder stones as well as stacked bile duct stones, were removed using a transpapillary procedure. |
| A newly designed duodenal stent enables stent placement for jejunal obstruction. |
| Clips and elastic band-assisted traction for biliary cannulation in a patient with an ectopic papilla within a juxtapapillary duodenal diverticulum. |
| Ectopic sebaceous glands of the esophagus presenting as sessile polyps. |
| Endoluminal radiofrequency ablation for ingrowth occlusion after endoscopic ultrasound-guided hepaticogastrostomy with bridging stent placement. |
| Endoscopic laser lithotripsy for an impacted pancreatic duct stone using a novel ultra-slim cholangiopancreatoscope via the minor papilla. |
| Endoscopic ultrasonography-guided removal of a migrated stent from the abdominal cavity after transgastric endoscopic ultrasonography-guided drainage of a biliary leak. |
| Long-term learning and not deskilling: a reassuring signal for computer-aided detection-assisted colonoscopy. |
| Management of short-term recurrent obstructive jaundice after endoscopic ultrasound guided hepaticogastrostomy. |
| Multi-holed fully covered self-expandable metal stent to dilate a benign hepaticojejunostomy anastomotic stricture. |
| Per-oral endoscopic tunneling transgastric drainage of an acute pancreatic necrotic collection. |
| Gastroenterology |
| A normal UCEIS is zero: A score divided by a common language. |
| AGA Institute Quality Indicators for Obesity Medication Use in Practice. |
| Hemodynamic Status as a Determinant Factor of Optimal Endoscopy Timing in Upper Gastrointestinal Bleeding: Results From an International Survey of 533 Clinicians. |
| Reduced Esophageal Hypervigilance and Symptom-Specific Anxiety in Barrett's Esophagus: A Deficient Alarm Signal for Gastroesophageal Reflux Disease-Associated Mucosal Injury. |
| Strategies to Promote Health Equity in Professional Society Clinical Guidance in Gastroenterology. |
| Gastrointest Endosc |
| Best of endoscopic retrograde cholangiopancreatography articles 2025. |
| Gut |
| Cause of a colorectal polyp in the caecum. |
| Insulin-like peptide 5: a new key player in IBS with diarrhoea and bile acid malabsorption? |
| Hepatology |
| Bundle it up-Care bundles for spontaneous bacterial peritonitis. |
| Fellows' Corner. |
| Letter to the Editor: Are we overestimating LSM-based HCC risk in MASLD? Addressing immortal time bias. |
| Letter to the Editor: Assessing HCC incidence and surveillance thresholds in non-cirrhotic MASLD. |
| Reply: Assessing HCC incidence and surveillance thresholds in non-cirrhotic MASLD. |
| Surgical resection for hepatocellular carcinoma: Leave no TACE? |
| When "remission" isn't enough: The unseen burden of autoimmune hepatitis. |
| Who improves, who doesn't and why? Defining improvement and drivers of outcomes in pediatric MASLD. |
| J Hepatol |
| From the Editor's Desk... |
Letters to the editors and authors’ replies
| Gastroenterology |
|---|
| Advancing Quiescent Crohn's Disease Management: Capsule Endoscopy-Guided Treat-to-Target Strategy or Standard Care? |
| Analysis of "Mebeverine and the Influence of Labeling in Adolescents With Irritable Bowel Syndrome or Functional Abdominal Pain Not Otherwise Specified: A 2 × 2 Randomized, Placebo-Controlled Trial". |
| Assessment of Methods in AOH1996 Studies for Pancreatic Ductal Adenocarcinoma Therapy. |
| Comments on "Electroacupuncture Reduces Duration of Postoperative Ileus After Laparoscopic Gastrectomy for Gastric Cancer". |
| Critical Role of Fucosyltransferase VII in Glycosylation-Dependent Regulatory T Cell Function in Inflammatory Bowel Disease. |
| Human-AI Interaction and Global Disparities in the Clinical Implementation of Medical AI. |
| Interpreting a Study on the Use of Electroacupuncture to Reduce Duration of Postoperative Ileus After Laparoscopic Gastrectomy for Gastric Cancer. |
| Is It Just About How Much You Drink? The Overlooked Role of Drinking Patterns in Fatty Liver Disease. |
| Macrophages and Mucosal Regeneration: Without Resolution of Identity and Mechanism, Are We Ready to Translate? |
| Methodological and Clinical Perspectives on a Study of Electroacupuncture After Laparoscopic Gastrectomy for Gastric Cancer. |
| Relief of Postoperative Intestinal Obstruction: Establishing and Perfecting Norms. |
| Revolutionizing Gastroenterology with Artificial Intelligence: Clinical Insights and Challenges. |
| Selection of Acupuncture Points to Reduce Duration of Postoperative Ileus. |
| Standardization is the Only Way Forward for Reliable Gastrointestinal Eosinophil Quantification. |
| Gastrointest Endosc |
| EndoFLIP-guided personalization of concomitant fundoplication during peroral endoscopic myotomy to optimize reflux prevention. |
| Is the "distinct border + II/IIIL pit pattern" truly an absolute indication for endoscopic resection in ulcerative colitis-associated neoplasia? |
| Necrosectomy in walled-off necrosis. |
| Refining peroral endoscopic myotomy/peroral endoscopic myotomy with concomitant endoscopic fundoplication gastroesophageal reflux assessment: actual myotomy length and multivariable regression. |
| Gut |
| Congenital sucrase-isomaltase mutations worsen IBS-linked V15F dysfunction and trafficking. |
| Heterogeneity and lack of standardisation in gut microbiome testing: a comparative assessment of French medical biology laboratories. |
| J Hepatol |
| "Advancing Clinical Trial Design and Patient Care in Hepatocellular Carcinoma". |
| Stereotactic body radiotherapy treatment for hepatocellular carcinoma with extensive macrovascular invasion. |
| Two lenses, same picture: interpreting nal-IRI in biliary tract cancer. |